Average Co-Inventor Count = 1.87
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Regeneron Pharmaceuticals, Inc. (5 from 1,343 patents)
5 patents:
1. 11116839 - Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
2. 10111953 - Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
3. 10076571 - Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
4. 9724411 - Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9
5. 8357371 - Methods for treating hypercholesterolemia using antibodies to PCSK9